|Report on the progress of regulations to protect stratospheric ozone : report to congress /
|Environmental Protection Agency, Washington, DC. Office of Toxic Substances.
| Environmental Protection Agency,
Air Pollutants--adverse effects ;
Hydrocarbons, Chlorinated--adverse effects ;
Hydrocarbons, Fluorinated--adverse effects ;
Air pollution ;
Chlorine organic compounds ;
Fluorine organic compounds ;
Clean air act amendments of 1977
|Received from HQ
|Some EPA libraries have a fiche copy filed under the call number shown.
As mandated by Section 155 of the Clean Air Act Amendments of 1977, EPA has submitted to Congress in February 1982, a report on the progress of regulation to protect stratospheric ozone covering the period from August 1979 to December 1981. The report reviews activities related to the production of stratospheric ozone from potential depletion due to emissions of chlorofluorocarbons (CFCs) and other ozone-depleting substances. Although the 1978 EPA & FDA regulations prohibited the manufacturing and processing of CFCs for non-essential aerosol uses, anticipated market growth in some non-aerosol uses may eventually offset the reductions achieved by the aerosol rule. In addition to CFCs, other potential ozone depleting substances are being investigated by EPA and other agencies. At the international level Japan and the European Economic Community have limited CFC-11 and CFC-12 production capacity to present levels while several nations are assessing the feasibility of reducing emissions from other uses. EPA and other Federal agencies will continue to monitor and support research to improve our understanding of atmospheric, health & environmental science of ozone depletion, technological capabilities and costs for limiting CFC emissions. Any decision regarding EPA action would be based on an evaluation of all these factors.
PB82-194036. Report to Congress.